fashion -WSS

fashion

author：Wikipedia 2025-09-30 11:15:06 - browse：24

The bacterium A. baylyi was engineered to detect a common cancer mutation. Courtesy of Josephine Wright

Dan Worthley, a gastroenterologist and cancer scientist at Colonoscopy Clinic in Brisbane, Australia, does thousands of colonoscopies a year, seeking and destroying precancerous polyps. It’s a practically surefire way to prevent colorectal cancer, but an unpleasant experience for patients. The future, Worthley hopes, will be much less onerous — and he’s developing a technology that, if it works one day, might make the experience more of a piece of cake.

Or, rather, a cup of yogurt — containing engineered bacteria that can detect and deliver a treatment for colorectal polyps or cancer. Worthley and colleagues at the University of California, San Diego, and the University of Adelaide published results in Science on Thursday that show they are one step closer to that far-off dream. In their paper, the researchers show a proof-of-concept engineered bacterium that can detect cancer DNA in the guts of mice and react to it by turning on certain cellular circuitry.

“I think it’s really cool. It introduces a new concept for how you can use cells as a sensor for something happening inside other cells,” said Mikhail Shapiro, a chemical and medical engineer at the California Institute of Technology who did not work on the study. “That can flip a switch inside those cells. In this case, it’s used for diagnostic output, but in principle it could be used for other things.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Does Paxlovid work in people vaccinated against Covid

entertainment

WSS

STAT Summit: Michael J. Fox on progress in Parkinson's research

Medicare Advantage overpayments discussion gets experts fired up

NIH confirmation hearing shows politicization of research

Lawmakers consider Medicare pay reforms for doctors

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

Profiling embryos to choose those with higher IQs is almost a reality

Wikipedia

fashion

explore

Supreme Court strikes down use of affirmative action

STAT Readout Newsletter: Today's biggest biotech updates

BioMarin wins approval for gene therapy to treat hemophilia A

Impact of Dobbs ruling felt at reproductive medicine meeting

Drug repurposing or repositioning? The language matters

FDA warns J&J's Abiomed: We will regulate your software

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

A preacher's new calling: Diversifying neuroscience research

Psychedelics group wrestles with new pharma identity

Male doctors called my cancer incurable. A female doctor showed it wasn't

entertainment

FDA warns J&J's Abiomed: We will regulate your software

Will Ozempic

Will Ozempic

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

Merck to acquire Harpoon Therapeutics for $680 million

Study suggests new cause of Down syndrome: cells linked to aging

entertainment

leisure time

focus

focus